Accelerate Diagnostics
AXDX
AXDX was delisted on the 14th of May, 2025.
56 hedge funds and large institutions have $194M invested in Accelerate Diagnostics in 2014 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 13 increasing their positions, 18 reducing their positions, and 7 closing their positions.
86% more capital invested
Capital invested by funds: $104M → $194M (+$89.6M)
57% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 7
8% more funds holding
Funds holding: 52 → 56 (+4)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
17% less call options, than puts
Call options by funds: $2.15M | Put options by funds: $2.59M
28% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$8.6M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.58M |
| 3 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
+$437K |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$270K |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$256K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$1.86M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$1.56M |
| 3 |
HCS
Harvest Capital Strategies
San Francisco,
California
|
-$963K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$632K |
| 5 |
CCM
Coe Capital Management
Highland Park,
Illinois
|
-$307K |
AXDX Hedge Fund Activity: Q1 2014 in Review
56 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Accelerate Diagnostics (AXDX) for Q1 2014, worth a combined $194M — up 86% from $104M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new AXDX positions and 7 closed out — a net gain of 4 holders — while 13 added to existing stakes and 18 trimmed.
The largest buyer was Invesco, opening a new position worth an estimated $8.6M. The largest seller was Goldman Sachs, cutting an estimated $1.86M.
- 56 institutional investors held Accelerate Diagnostics (AXDX) as of Q1 2014, up from 52 in Q4 2013.
- Funds reported $194M of Accelerate Diagnostics stock for Q1 2014, up 86% quarter-over-quarter.
- 11 funds opened new Accelerate Diagnostics positions in Q1 2014 and 7 closed out, a net change of +4 holders.
- The largest Accelerate Diagnostics buyer in Q1 2014 was Invesco, an estimated $8.6M added.
- The largest Accelerate Diagnostics seller in Q1 2014 was Goldman Sachs, an estimated $1.86M sold.
Based on aggregated 13F filings for Q1 2014.